| Company Name | Symbol | Price | Prev. Close | Volume | 1 Year (%) |
|---|---|---|---|---|---|
| Applied Materials | AMAT | 554.50 | 592.79 | 12,708,127 | +363.72 (190.65%) |
| Garrett Motion Inc. - Common Stock | GTX | 32.25 | 33.19 | 3,267,858 | +21.12 (189.76%) |
| uniQure N.V. - Ordinary Shares | QURE | 41.41 | 41.36 | 2,221,345 | +27.10 (189.38%) |
| Definium Therapeutics, Inc. - Common Shares | DFTX | 44.48 | 44.33 | 2,588,243 | +29.10 (189.21%) |
| Backblaze, Inc. - Common Stock | BLZE | 15.84 | 15.30 | 2,972,571 | +10.36 (189.05%) |
| Crinetics Pharmaceuticals, Inc. - Common Stock | CRNX | 83.53 | 42.03 | 80,948,407 | +54.47 (187.44%) |
| C4 Therapeutics, Inc. - Common Stock | CCCC | 4.350 | 4.140 | 4,373,751 | +2.83 (186.18%) |
| Tetra Technologies, Inc. Common Stock | TTI | 9.260 | 9.400 | 1,473,723 | +6.02 (185.80%) |
| Tradr 2X Long GEV Daily ETF | GEVX | 23.78 | 27.44 | 527,445 | +15.45 (185.41%) |
| Tilly's, Inc. Common Stock | TLYS | 4.250 | 4.300 | 144,323 | +2.76 (185.23%) |
| Anteris Technologies Global Corp. - Common Stock | AVR | 9.920 | 10.57 | 1,212,567 | +6.44 (185.06%) |
| Fate Therapeutics, Inc. - Common Stock | FATE | 3.020 | 2.990 | 2,421,452 | +1.96 (184.91%) |
| Esperion Therapeutics, Inc. - Common Stock | ESPR | 3.160 | 3.150 | 7,502,509 | +2.05 (184.68%) |
| Sterling Infrastructure, Inc. - Common Stock | STRL | 674.39 | 717.11 | 658,927 | +437.39 (184.55%) |
| Olema Pharmaceuticals, Inc. - Common Stock | OLMA | 12.63 | 12.77 | 1,597,494 | +8.18 (183.82%) |
| Onto Innovation Inc. Common Stock | ONTO | 279.93 | 303.86 | 1,499,727 | +181.23 (183.62%) |
| Zenas BioPharma, Inc. - Common Stock | ZBIO | 27.68 | 26.45 | 898,542 | +17.89 (182.74%) |
| Stoke Therapeutics, Inc. - Common Stock | STOK | 33.02 | 32.43 | 904,639 | +21.33 (182.46%) |
| Protagonist Therapeutics, Inc. - Common Stock | PTGX | 140.85 | 131.50 | 1,374,383 | +90.98 (182.43%) |
| Electrovaya Inc. - Common Shares | ELVA | 8.980 | 9.670 | 501,215 | +5.80 (182.39%) |
| T-Rex 2X Inverse MSTR Daily Target ETF | MSTZ | 11.84 | 11.08 | 16,390,733 | +7.64 (181.90%) |
| Ligand Pharmaceuticals Incorporated - Common Stock | LGND | 319.43 | 320.42 | 316,475 | +205.67 (180.79%) |
| Immunome, Inc. - Common Stock | IMNM | 24.39 | 23.90 | 1,561,518 | +15.70 (180.67%) |
| Tharimmune, Inc. - Common Stock | THAR | 4.740 | 4.740 | 0 | +3.05 (180.46%) |
| UroGen Pharma Ltd. - Ordinary Shares | URGN | 37.75 | 37.41 | 914,054 | +24.26 (179.84%) |
| InnovAge Holding Corp. - Common Stock | INNV | 11.65 | 12.11 | 345,928 | +7.48 (179.38%) |
| Taysha Gene Therapies, Inc. - Common Stock | TSHA | 6.500 | 6.380 | 3,680,884 | +4.16 (177.78%) |
| Xometry, Inc. - Class A Common Stock | XMTR | 93.10 | 94.30 | 545,362 | +59.41 (176.34%) |
| Astronics Corporation - Common Stock | ATRO | 70.19 | 71.79 | 934,165 | +44.75 (175.87%) |
| Surrozen, Inc. - Common Stock | SRZN | 23.01 | 23.66 | 199,398 | +14.66 (175.57%) |
